Evidence map›Paper›PMID 19528208›Full record

ArticleInfection and immunity2009

Inhibition of Staphylococcus epidermidis biofilm formation by rabbit polyclonal antibodies against the SesC protein.

Mohammad Shahrooei, Vishal Hira, Benoit Stijlemans, Rita Merckx, Peter W M Hermans, Johan Van Eldere

Abstract read
In one paragraph

Article in Infection and immunity, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Virulence Factors in Coagulase-Negative Staphylococci.Pathogens (Basel, Switzerland) · 2021
    Review
  9. Staphylococcal Vaccine Antigens related to biofilm formation.Human vaccines & immunotherapeutics · 2021
    Review
  10. Article
  11. Surface Proteins ofFrontiers in microbiology · 2020
    Review
  12. Review
  13. Article
  14. Purification of PIA and rSesC as Putative Vaccine Candidates AgainstReports of biochemistry & molecular biology · 2019
    Article
  15. Review
  16. Article
  17. Article
  18. SesI May Be Associated with the Invasiveness ofFrontiers in microbiology · 2017
    Article
  19. Pathogenic Mechanisms and Host Interactions inFrontiers in microbiology · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Mohammad ShahrooeiDepartment of Medical Diagnostic Sciences, Laboratory of Medical Microbiology, KU Leuven, UZ Gasthuisberg, B-3000 Leuven, Belgium. Mohammad.Shahrooei@med.kuleuven.be
Vishal Hira
Benoit Stijlemans
Rita Merckx
Peter W M Hermans
Johan Van Eldere
KU Leuven · BEErasmus MC - Sophia Children’s Hospital · NLRadboud University Nijmegen · NLVrije Universiteit Brussel · BE

Funding

Wellcome Trust
6 · The paper itself

Abstract

Several well-studied proteins with defined roles in Staphylococcus epidermidis biofilm formation are LPXTG motif-containing proteins. Here, we investigate the possible use of the LPXTG motif-containing protein SesC (S. epidermidis surface protein C; accession no. NP_765787) as a target for antibodies to prevent biofilm formation. In vitro and in a in vivo rat model of catheter infection, gene and protein expression analysis showed that SesC is expressed more strongly in biofilm-associated cells than in planktonic cells and is expressed particularly during the late phase of in vivo biofilm formation. Polyclonal rabbit antibodies raised against SesC reduced the fibrinogen-binding ability of S. epidermidis RP62A and Staphylococcus aureus RN4220 transformants expressing SesC, inhibited in vitro biofilm formation by S. epidermidis strains 10b and 1457, and significantly reduced the numbers of bacteria in a 1-day-old in vivo biofilm (P < 0.001, one-way analysis of variance). Our findings revealed that SesC is a promising target for prevention and treatment of S. epidermidis biofilms because it affects both the primary attachment and biofilm accumulation phases. The precise role of SesC in biofilm formation remains to be identified.

Indexed as

BiofilmsAnimalsAntibodies, BacterialBacterial ProteinsFibrinogenHumansRabbitsRatsRats, Inbred F344Staphylococcus epidermidisAntibodies, BacterialBacterial ProteinsFibrinogen

Identifiers

PMID19528208
PMCPMC2738011
OpenAlexW2104411273

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.